The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zyvox 100 mg/5 ml granules for oral suspension

100
mg/5ml Granules for oral suspension


Pfizer Healthcare IrelandPA0822/143/001

Main Information

Trade NameZyvox 100 mg/5 ml granules for oral suspension
Active SubstancesLinezolid
Strength100
mg/5ml
Dosage FormGranules for oral suspension
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/143/001

Group Information

ATC CodeJ01XX Other antibacterials
J01XX08 linezolid

Status

Authorised/WithdrawnAuthorised
Licence Issued27/07/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back